Article
The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
17 Jun 2013
Abstract excerpt
Historically, one of the key problems in neglected disease drug discovery has been identifying new and interesting chemotypes. Phenotypic screening of the malaria parasite, Plasmodium falciparum has yielded almost 30,000 submicromolar hits in recent years. To make this collection more accessible, a collection of 400 chemotypes has been assembled, termed the Malaria Box. Half of these compounds were selected based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
